Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Oct;190(4):1240-4.
doi: 10.1016/j.juro.2013.03.114. Epub 2013 Apr 6.

Stage I testicular seminoma: a SEER analysis of contemporary adjuvant radiotherapy trends

Alan E Thong  1 , Daphne Y Lichtensztajn, Leanne Almario, Alexandre Ingels, Scarlett Lin Gomez, Mark L Gonzalgo
Affiliations

Stage I testicular seminoma: a SEER analysis of contemporary adjuvant radiotherapy trends

Alan E Thong et al. J Urol. 2013 Oct.

Abstract

Purpose: Patients with clinical stage I testicular seminoma have historically been treated with adjuvant radiotherapy in the United States. However, nearly 80% of patients on surveillance will not experience relapse and even with relapse, salvage rates approach 100%. It remains unclear how practice patterns have changed with recently accumulating evidence and changes in guidelines. In a population based setting we evaluated contemporary trends and factors that may affect the use of adjuvant radiotherapy.

Materials and methods: A total of 8,151 men diagnosed with stage I testicular seminoma from 2000 to 2009 were identified in the national SEER (Surveillance, Epidemiology, and End Results) registry. A multivariate regression model was constructed to analyze the association of year, age, race, socioeconomic status, SEER region, pathological stage and tumor size with the administration of adjuvant radiotherapy.

Results: The use of adjuvant radiotherapy decreased significantly from 2000 to 2009. In 2000, 74.7% of patients received radiation, compared with only 37.7% of patients in 2009 (p <0.0001). Later year of diagnosis was significantly associated with decreased odds of receiving adjuvant radiotherapy (p <0.0001, 2000 to 2005 vs 2006 to 2009, OR 0.40, 95% CI 0.36-0.44). Men age 35 years or older (p <0.0002, OR 1.20, 95% CI 1.09-1.32) and men in the highest socioeconomic index quartile (p <0.0001, OR 1.34, 95% CI 1.16-1.54) were more likely to receive adjuvant radiotherapy.

Conclusions: The use of adjuvant radiotherapy for clinical stage I testicular seminoma has decreased significantly in the last decade. Older age and higher socioeconomic status are associated with higher rates of adjuvant radiotherapy.

Keywords: CS; CT; EAU; EOD; European Association of Urology; Extent of Disease; NCCN; National Comprehensive Cancer Network; RT; SEER program; SES; adjuvant; chemotherapy; collaborative stage; computerized tomography; radiotherapy; seminoma; socioeconomic status.

PubMed Disclaimer

Figures

Figure
Figure
Proportion of men receiving adjuvant RT for stage I seminoma 2000 to 2009 with Joinpoint regression lines showing rapid decrease (arrow) in use after 2006.
See this image and copyright information in PMC

References

    1. Howlader N, Noone A, Krapcho M, et al. SEER Cancer Statistics Review, 1975–2009, based on November 2011 SEER data submission, posted to the SEER web site April 2012. Available at http://seer.cancer.gov/csr/1975_2009_pops09/index.html. Accessed January 7, 2013.
    1. National Comprehensive Cancer Network. Testicular cancer. 2012 Available at www.nccn.org/professionals/physician_gls/pdf/testicular.pdf. Accessed January 7, 2013.
    1. Mead GM, Fossa SD, Oliver RT, et al. Randomized trials in 2466 patients with stage I seminoma: patterns of relapse and follow-up. J Natl Cancer Inst. 2011;103:241. - PubMed
    1. Osswald M, Harlan LC, Penson D, et al. Treatment of a population based sample of men diagnosed with testicular cancer in the United States. Urol Oncol. 2009;27:604. - PMC - PubMed
    1. Warde P, Specht L, Horwich A, et al. Prognostic factors for relapse in stage I seminoma managed by surveillance: a pooled analysis. J Clin Oncol. 2002;20:4448. - PubMed